The American Medical Association has published a detailed profile of Oregon's Senate Bill 951, calling it the first-in-the-nation law curbing corporate medicine and positioning it as a model for physician advocacy nationwide. Signed by Governor Tina Kotek on June 9, 2025, SB 951 took effect January 1, 2026, for newly formed management services organizations, with existing MSOs given until January 1, 2029, to comply. The AMA's endorsement elevates the law from a state-level regulatory experiment to a template for the organized medicine movement's broader campaign against private equity consolidation in physician practices.

SB 951's provisions go further than any prior state law. It prohibits an MSO and its affiliates from owning or controlling a majority interest in the medical practice it manages. It bans noncompete agreements for employed physicians unless they hold at least 10% equity in the practice. It voids non-disclosure and non-disparagement clauses except for legitimate trade secret protections. And it requires transparency in the financial relationship between MSOs and the practices they support. The AMA's profile arrives as other states accelerate their own efforts: California enacted SB 351 in October 2025, codifying corporate practice restrictions and limiting private equity control over medical and dental practices; Massachusetts passed H 5159 in January 2025, adding notice requirements for significant equity investor transactions; Indiana enacted HB 1666 in May 2025 enhancing attorney general oversight; and North Carolina is considering SB 570 to prohibit clinical interference from MSOs.

For Oregon providers, the AMA's national spotlight cuts both ways. On one hand, it validates the state's pioneering approach and may attract federal legislative interest in standardizing MSO restrictions. On the other, it makes Oregon the primary testing ground — every enforcement action, every compliance dispute, every legal challenge under SB 951 will be scrutinized by health systems, private equity firms, and legislators in all 50 states. The PeaceHealth-ApolloMD dispute in Lane County is already functioning as the law's first major test case, and its resolution will shape whether SB 951's model is adopted or avoided by other states.

Watch for whether the AMA formally includes SB 951-style legislation in its model state legislation recommendations at its upcoming policy meetings, which would dramatically accelerate adoption in other states. Monitor whether the wave of state-level CPOM bills produces a federal legislative proposal — several members of Congress have signaled interest in national MSO transparency requirements. Also track whether Oregon's enforcement agencies demonstrate the capacity to actually investigate and penalize SB 951 violations, since the law's national credibility depends entirely on whether it has teeth in practice, not just on paper.